The microbiomes of the eyelid and buccal area of patients with uveitic glaucoma/Experiment 1

From BugSigDB


Needs review

Curated date: 2025/08/28

Curator: Anne-mariesharp

Revision editor(s): Anne-mariesharp

Subjects

Location of subjects
South Korea
Host species Species from which microbiome was sampled. Contact us to have more species added.
Homo sapiens
Body site Anatomical site where microbial samples were extracted from according to the Uber Anatomy Ontology
Eyelid Blephara,Blepharon,Eye lid,Palpebra,Palpebrae,Eyelid,eyelid
Condition The experimental condition / phenotype studied according to the Experimental Factor Ontology
Glaucoma glaucoma,glaucoma (disease),Glaucoma (disorder),Glaucoma associated with other ocular disorders,Glaucoma associated with other ocular disorders (disorder),Glaucoma associated with other ocular disorders NOS,Glaucoma associated with other ocular disorders NOS (disorder),GLAUCOMA NEC,Glaucoma NOS,Glaucoma NOS (disorder),Glaucoma, NOS,Glaucomas,Other specified forms of glaucoma,Other specified forms of glaucoma (disorder),Other specified glaucoma,Other specified glaucoma NOS,Other specified glaucoma NOS (disorder),Unspecified glaucoma,Glaucoma
Group 0 name Corresponds to the control (unexposed) group for case-control studies
Controls
Group 1 name Corresponds to the case (exposed) group for case-control studies
UG (Uveitic Glaucoma)
Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
Patients with Uveitic Glaucoma
Group 0 sample size Number of subjects in the control (unexposed) group
25
Group 1 sample size Number of subjects in the case (exposed) group
20
Antibiotics exclusion Number of days without antibiotics usage (if applicable) and other antibiotics-related criteria used to exclude participants (if any)
1 month

Lab analysis

Sequencing type
16S
16S variable region One or more hypervariable region(s) of the bacterial 16S gene
V3-V4
Sequencing platform Manufacturer and experimental platform used for quantifying microbial abundance
Illumina

Statistical Analysis

Data transformation Data transformation applied to microbial abundance measurements prior to differential abundance testing (if any).
raw counts
Statistical test
edgeR
Significance threshold p-value or FDR threshold used for differential abundance testing (if any)
0.01
MHT correction Have statistical tests be corrected for multiple hypothesis testing (MHT)?
Yes

Alpha Diversity

Shannon Estimator of species richness and species evenness: more weight on species richness
decreased
Richness Number of species
unchanged

Signature 1

Needs review

Curated date: 2025/08/29

Curator: Anne-mariesharp

Revision editor(s): Anne-mariesharp

Source: Figure 5, Supplementary Table S1

Description: Differentially abundant taxa between UG patients and control participants

Abundance in Group 1: increased abundance in UG (Uveitic Glaucoma)

NCBI Quality ControlLinks
Bacillariophyta
Bacteroides
Brevundimonas
Buttiauxella
Calidifontibacter
Candidatus Carsonella
Chryseobacterium
Citrobacter
Dermacoccus
Eggerthia
Escherichia/Shigella sp.
Faecalibacterium
Fontibacillus
Kandleria
Kocuria
Paenibacillus
Planctopirus
Roseburia
Soonwooa
Sulfophobococcus
Sulfurisphaera
Tepidimonas
Vampirovibrio
Vibrionimonas
Clostridium XVIIIClostridium XVIII

Revision editor(s): Anne-mariesharp

Signature 2

Needs review

Curated date: 2025/08/29

Curator: Anne-mariesharp

Revision editor(s): Anne-mariesharp

Source: Figure 5, Supplementary Table S1

Description: Differentially abundant taxa between UG patients and control participants

Abundance in Group 1: decreased abundance in UG (Uveitic Glaucoma)

NCBI Quality ControlLinks
Bifidobacterium
Dermabacter
Dolosigranulum
Finegoldia
Halalkalibacillus
Klebsiella
Lactobacillus
Lactococcus
Moellerella
Morganella
Pluralibacter
Pseudocitrobacter
Psychrobacter
Serratia
Stenotrophomonas
Variovorax
Weissella
Xylella

Revision editor(s): Anne-mariesharp